Prognostic Value of CD44 Splice Variants in Human Stage III Cervical Cancer

Author： Kainz C.   Kohlberger P.   Tempfer C.   Sliutz G.   Gitsch G.   Reinthaller A.   Breitenecker G.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.31, Iss.10, 1995-09, pp. : 1706-1709

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prognostic Value of Immunohistochemically Detected CD44 Isoforms CD44v5, CD44v7-8 in Human Breast Cancer

By Tempfer C.   Losch A.   Heinzl H.   Hausler G.   Hanzal E.   Kolbl H.   Breitenecker G.   Kainz C.  

European Journal of Cancer, Vol. 32, Iss. 11, 1996-10 ,pp. : 2023-2025

Elsevier

Access to resources Recommend Favorite

No evidence for cancer-related CD44 splice variants in primary and metastatic colorectal cancer

By Givehchian M.   Worner S.   Strater J.   Zoller M.   Heuschen U.   Heuschen G.   Lehnert T.   Herfarth C.   von Knebel Doeberitz M.  

European Journal of Cancer, Vol. 34, Iss. 7, 1998-06 ,pp. : 1099-1104

Elsevier

Access to resources Recommend Favorite

Overexpression of CD44 Variants 6 and 7 in Human Endometrial Cancer

By Katsura M.   Furumoto H.   Nishimura M.   Kamada M.   Aono T.  

Gynecologic Oncology, Vol. 71, Iss. 2, 1998-11 ,pp. : 185-189

Elsevier

Access to resources Recommend Favorite

Overexpression of CD44 Variant 6 in Human Endometrial Cancer and Its Prognostic Significance

By Ayhan A.   Tok E.C.   Bildirici I.   Ayhan A.  

Gynecologic Oncology, Vol. 80, Iss. 3, 2001-03 ,pp. : 355-358

Elsevier

Access to resources Recommend Favorite

Significance of survivin expression: Prognostic value and survival in stage III non-small cell lung cancer

By          

Experimental and Therapeutic Medicine, Vol. 3, Iss. 6, 2012-01 ,pp. : 983-988

Spandidos Publications

Access to resources Recommend Favorite